The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who...
New research highlights the confusion over legality of medical cannabis in the UK.
While CBD is generally considered to be safe, new animal studies have shown alterations in brains and behaviour in offspring exposed to the cannabinoid during pregnancy....
Experts examine how Medical Cannabis may have the potential to improve the quality of life for individuals with Muscular Dystrophy. The article is an excerpt from...
The Cognalyzer® scans EEG (brainwaves) of consumers and leverages AI to quantify if a person is experiencing psychoactive effects.
MRX1 demonstrated “cardioprotective effects” in a pre-clinical study.
Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a new international vertically integrated cannabis company....
A new study suggests that adults aged 65 and older experience “considerable improvements” in their health and wellbeing when prescribed cannabis-based medicines. The use of medical...
A pilot scheme introducing the legal sale and production of cannabis in the Netherlands is due to be expanded to eight more cities across the country....
A new research paper has highlighted how many people are still accessing cannabis illegally for medicinal purposes in the UK, over five years on from the...
Script Assist's medical cannabis technology platform will now be available on a software as a service (SaaS) basis for the first time.
Lyphe is proud to announce the launch of its new low-cost medical cannabis line, Noidecs Vital, designed to address affordability issues for medical patients. Recognising the...
